诚信认证:
工商注册信息已核实!
![](https://img.antpedia.com/cbook/dist_templates/0/images/icon14.png)
![](https://cbook.antpedia.com/attachments/design/6751/1682393653-0588.jpg)
RO5126766 (CH5126766),946128-88-7,10mM in DMSO
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
阿拉丁 | 总代理 | 中国 | 现货 |
性能特点
InformationRO5126766 (CH5126766, VS 6766, CKI-27, R-7304, RG-7304) is a dualRAF/MEKinhibitor wit
货号 | 规格 | CAS号 | 价格 | 操作 |
---|---|---|---|---|
R427048-1ml | 1ml | 946128-88-7 | ¥720.90 | 询底价 |
中文名:RO5126766 (CH5126766)
英文名:RO5126766 (CH5126766)
英文别名:946128-88-7|RO5126766|avutometinib|CH5126766|RO-5126766|RO-5126766 free base|Ro 5126766|CH-5126766|RO5126766(CH5126766)|RG-7304|VS-6766|CKI-27|3-[[2-[(methylaminosulfonyl)amino]-3-fluoropyridin-4-yl]methyl]-4-methyl-7-[(pyrimidin-2-yl)oxy]-2H-1-benzopyran
纯度:10mM in DMSO
货号:R427048
Cas号:946128-88-7
存储温度:-80℃储存
产品介绍:
Information
RO5126766 (CH5126766, VS 6766, CKI-27, R-7304, RG-7304) is a dualRAF/MEKinhibitor withIC50of 8.2 nM,19 nM, 56 nM, and 160 nM for BRAF V600E, BRAF, CRAF, and MEK1, respectively. Phase 1.
Targets
BRAF V600E (cell-free assay); BRAF (cell-free assay); CRAF (cell-free assay); MEK1 (cell-free assay) 8.2 nM; 19 nM; 56 nM; 160 nM
In vitro
In HCT116 KRAS-mutant colorectal cancer cells, CH5126766 significantly reduces the levels of phospho-MEK and phospho-ERK. CH5126766 inhibits RAF kinase by binding to MEK1, and causes MEK to become a dominant negative inhibitor of RAF. In Raf or RAS-mutant cell lines SK-MEL-28, SK-MEL-2, MIAPaCa-2, SW480, HCT116, and PC3 cells, CH5126766 inhibits cell growth with IC50 of 65, 28, 40, 46, and 277 nM, respectively. In two melanoma cell lines with the BRAF V600E or NRAS mutation, RO5126766 induces G1 cell cycle arrest accompanied by up-regulation of the CDK inhibitor p27 and down-regulation of cyclinD1.
In vivo
In an HCT116 (G13D KRAS) mouse xenograft model, CH5126766 (25 mg/kg, p.o.) inhibits ERK signaling output more effectively than a standard MEK inhibitor that induces MEK phosphorylation and has potent antitumor activity. In the HCT116 (K-ras) and COLO205 (B-raf) mutant xenografts, CH5126766 (0.3 mg/kg) causes significant decreases in [18\u2009F]FDG uptake. In the SK-MEL-2 xenograft model, RO5126766 also suppresses the tumor growth.
Cell Research(from reference)
Cell lines:SK-MEL-28, SK-MEL-2, MIAPaCa-2, SW480, A549, HCT15, HCT116, and PC3 cells
Concentrations:~10 μM
Incubation Time:72 h
查看阿拉丁官网此产品相关对应页面:https://www.aladdin-e.com/zh_cn/R427048.html
RO5126766 (CH5126766),946128-88-7,10mM in DMSO信息由上海阿拉丁生化科技股份有限公司为您提供,如您想了解更多关于RO5126766 (CH5126766),946128-88-7,10mM in DMSO报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途